Hedgepath Pharmaceuticals Inc. (HPPI), of Tampa, Fla., said it closed a $1.5 million interim private common stock financing. Funds were secured from Hedgepath LLC, the firm's majority stockholder, which, under the terms, will purchase 20 million shares of HPPI common stock.